Prevention of recurrent nephrolithiasis

American Family Physician

Volumn 60, Issue 8, 1999, Pages 2269-2276

  Goldfarb, David S ^a   Coe, Fredric L ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CALCIUM; CHLORTALIDONE; CITRATE POTASSIUM; CITRATE SODIUM; CYSTINE; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; URIC ACID;

CALCIUM STONE; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; FLUID INTAKE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERPARATHYROIDISM; HYPERURICOSURIA; KIDNEY TUBULE ACIDOSIS; NEPHROLITHIASIS; PROTEIN INTAKE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SALT INTAKE; SARCOIDOSIS; URIC ACID STONE; URINALYSIS;

CONSENSUS DEVELOPMENT CONFERENCES, NIH; HUMANS; KIDNEY CALCULI; RECURRENCE; RISK FACTORS; UNITED STATES;

EID: 0033571813     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327:1141-52.
2. Consensus conference. Prevention and treatment of kidney stones. Retrieved October 12, 1999, from the World Wide Web: http://odp.od.nih.gov/ consensus/cons/067/067_intro.htm.
3. Curhan GC, Rimm EB, Willett WC, Stampfer MJ. Regional variation in nephrolithiasis incidence and prevalence among United States men. J Urol 1994; 151:838-41.
4. Bruce RG, Munch LC, Hoven AD, Jerauld RS, Greenburg R, Porter WH, et al. Urolithiasis associated with the protease inhibitor indinavir. Urology 1997;50:513-8.
5. Goldfarb S. Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 1988;34:544-55.
6. Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease. J Urol 1996;155:432-40.
7. Rodman JS, Sosa RE, Lopez MA. Diagnosis and treatment of uric acid calculi. In: Coe FL, Favus MJ, Pak CY, Parks JH, Preminger GM, eds. Kidney stones: medical and surgical management. New York: Lippincott-Raven, 1996:973-89.
8. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128:534-40.
9. Curhan GC, Willett WC, Rimm EB, Spiegefman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996;143:240-7.
10. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
11. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;125:497-504.
12. Halabe A, Sutton RA. Primary hyperparathyroidism as a cause of calcium nephrolithiasis. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven, 1992:671-84.
13. Platt JF. Urinary obstruction. Radiol Clin North Am 1996;34:1113-29.
14. Miller OF, Rineer SK, Reichard SR, Buckley RG, Donovan MS, Graham IR, et al. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology 1998;52:982-7.
15. Goldfarb DS, Parks JH, Coe FL. Renal stone disease in older adults. Clin Geriatr Med 1998;14:367-82.
16. Milliner DS, Murphy ME. Urolithiasis in pediatric patients. Mayo Clin Proc 1993;68:241-8.
17. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 1985;11:257-9.
18. Wabner CL, Pak CY. Effect of orange juice consumption on urinary stone risk factors. J Urol 1993;149:1405-8.
19. Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol 1996;156:907-9.
20. Goldfarb DS, Coe FL. Beverages, diet, and prevention of kidney stones. Am J Kidney Dis 1999;33: 398-400.
21. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997;51:894-900.
22. Pak CY. Southwestern Internal Medicine Conference: medical management of nephrolithiasis - a new, simplified approach for general practice. Am J Med Sci 1997;313:215-9.
23. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int 1996;50:1706-12.
24. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculus recurrence but magnesium hydroxide does not. J Urol 1988;139:679-84.
25. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986;30:85-90.
26. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2069-73.
27. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315: 1386-9.
28. Pacifici R, Rothstein M, Rifas L, Lau KW, Baylink D, Avioli LV, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990;71:138-45.
29. Weisinger JR. New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 1996;49:1507-18.
30. Fournier A, Ghazali A, Bataille P, Cohen Solal M, Marie A, Brazier M, et al. Bone involvement in idiopathic calcium-stone formers. In: Coe FL, Favus MJ, Pak CY, Parks JH, Preminger GM, eds. Kidney stones: medical and surgical management. New York: Lippincott-Raven, 1996:921-38.
31. Jones G, Nguyen T, Sambrook PN, Eisman JA. Thiazide diuretics and fractures. Can meta-analysis help? J Bone Miner Res 1995;10:106-11.
32. Alonzo E, Bellorin-Font E, Machado C, Carlini R, Paz-Martinez V, Weisinger JR. A controlled long-term study on the effect of alendronate in idiopathic hypercalciuria. J Am Soc Nephrol 1996;7:11786.
33. Levine BS, Rodman JS, Wienerman S, Bockman RS, Lane JM, Chapman DS. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis Am J Clin Nutr 1994;60:592-6.
34. Coe FL, Parks JH, Webb DR. Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int 1992;41:139-42.